Selecting an API manufacturing partner involves more than assessing technical capabilities and regulatory compliance. Long-term success depends on working with a supplier that can consistently deliver quality, manage risk, and maintain reliable operations.
In complex pharmaceutical manufacturing environments, deviations and operational challenges can occur. The real differentiator is how an organization responds. Strong investigation processes, effective Root Cause Analysis (RCA), and meaningful Corrective and Preventive Actions (CAPAs) help manufacturers identify underlying causes, reduce recurrence, and drive continuous improvement.
At TAPI, these principles are embedded within our Quality and EHS&S programs, where teams continuously strengthen investigation capabilities, root cause analysis practices, and CAPA effectiveness to support operational reliability and long-term customer confidence.
Here are five questions every pharmaceutical company should ask when evaluating a potential API manufacturing partner.
1. How Does the Organization Investigate Problems?
When an issue occurs, the quality of the investigation often determines the quality of the outcome.
Organizations that focus only on the immediate event may resolve the symptoms without addressing the underlying cause. More mature manufacturers take a systematic approach, seeking to understand not only what happened, but why it happened and what improvements can prevent similar events in the future.
Robust investigations help uncover process gaps, identify contributing factors, and support continuous improvement across operations. Effective investigation practices include structured fact gathering, root cause analysis, interviewing, and hypothesis testing to ensure conclusions are evidence-based rather than assumption-driven.
Why it matters: Strong investigation practices help reduce operational risk, improve manufacturing reliability, and strengthen supply continuity.
2. Does the Supplier Look Beyond “Human Error”?
When an issue occurs, “human error” is often one of the first explanations considered. However, leading manufacturers recognize that human error is rarely the complete story.
Many operational events are influenced by broader factors such as training, process design, communication, workplace conditions, equipment, workload, and procedural clarity. Focusing exclusively on an individual’s actions can overlook opportunities to strengthen the system itself. TAPI’s investigation approach emphasizes that human error should be treated as a contributing factor rather than automatically being defined as the root cause.
Organizations that examine both human and systemic contributors are often better positioned to identify meaningful improvements and reduce the likelihood of recurrence. A culture focused on learning and prevention can drive stronger long-term performance than one focused primarily on assigning blame.
Why it matters: A systems-based approach can lead to more sustainable improvements and a more resilient manufacturing operation.
3. How Are Root Causes Identified and Verified?
Not all root cause analyses are created equally.
Effective RCA relies on facts, evidence, and structured problem-solving methods rather than assumptions. The goal is to move beyond symptoms and identify the underlying factors that contributed to an event.
Established techniques such as the 5 Whys, Fishbone Analysis, logic trees, and cross-functional investigations can help organizations better understand complex issues and develop more effective solutions. The most effective programs emphasize objective evaluation, data gathering, process knowledge, and collaboration to verify root causes before implementing corrective actions.
At TAPI, strengthening investigation of quality and root cause analysis capabilities is part of an ongoing commitment to operational excellence and continuous improvement.
Why it matters: Reliable root cause analysis forms the foundation for meaningful corrective and preventive actions.
4. How Does the Organization Prevent Problems from Happening Again?
A completed investigation delivers value only when it leads to action.
Corrective and Preventive Actions (CAPAs) are intended to address validated root causes and reduce the likelihood of recurrence. Effective CAPAs focus on strengthening processes, controls, training, systems, and operational safeguards rather than simply addressing immediate symptoms.
The most mature quality organizations understand that successful CAPAs are directly linked to verified root causes and designed to improve system performance over time. By targeting the underlying causes of an issue, organizations can improve operational consistency, enhance quality and safety systems, and support long-term manufacturing reliability.
At TAPI, quality of the investigation and CAPA effectiveness are key components of continuous improvement efforts aimed at supporting safety in our workplace, dependable product quality, and reliable supply for customers.
Why it matters: Effective CAPAs help transform investigations into measurable improvements.
5. How Does the Supplier Measure Success?
Completing an action does not automatically mean a problem has been solved.
Leading manufacturers evaluate whether their improvements are truly effective by monitoring performance over time, reviewing trends, and verifying that actions deliver measurable results. Effective programs focus on sustainability, not simply closure.
Questions organizations often consider include:
- Has the issue reoccurred?
- Has the root cause been eliminated or controlled?
- Is there a measurable improvement?
- Is the solution sustainable over time?
These questions help distinguish organizations focused on continuous improvement from those focused solely on completing activities.
Why it matters: Long-term effectiveness is often a better indicator of supplier maturity than the completion of individual actions.
Reliability Is Built Through Continuous Improvement
When selecting an API manufacturing partner, technical expertise and regulatory compliance remain essential. However, they are only part of the picture.
The strength of a manufacturer’s investigation processes, root cause analysis capabilities, and continuous improvement culture can provide valuable insight into how it manages risk, responds to challenges, and supports reliable supply. Organizations that invest in understanding problems, identifying underlying causes, and implementing effective improvements are better positioned to strengthen performance over time and support the evolving needs of their customers.
At TAPI, continuous improvement is embedded in the way we approach quality, safety and operational excellence. Across our global network, we invest in strengthening investigation capabilities, advancing root cause analysis methodologies, and enhancing CAPA effectiveness to help identify systemic opportunities for improvement and reduce the potential for recurring events. Approximately 300 employees across TAPI were trained through the Human Error Investigations and RCA/CAPA & CAPA Effectiveness training programs in 2026. These efforts support our broader commitment to product quality, operational reliability, and long-term partnership with our customers.
As pharmaceutical supply chains become increasingly complex, manufacturers are looking beyond compliance alone. They are seeking partners with the quality culture, operational discipline, and continuous improvement mindset needed to support dependable supply and long-term success.
